"Ozempic breath" is boosting Hershey's sales of mints and gum
A business story about how demand for breath-freshening products has increased among users of weight-loss medications like Ozempic is receiving coverage. The phenomenon appears linked to side effects associated with these popular drugs. Hershey's mint and gum sales have reportedly benefited from this trend.
CBS News covered this as a straightforward business story, examining how a consumer health trend is creating unexpected market opportunities for major manufacturers. The framing treats the phenomenon as a notable intersection of pharmaceutical trends and consumer product demand.
PJ Media's coverage appears unrelated to the Ozempic-breath story, instead focusing on allegations about a former FBI official. This represents a significant editorial divergence from the business-focused reporting on the left.
Key Differences
- CBS News reported on the Ozempic-breath consumer trend while PJ Media's coverage focused on an entirely different political narrative, suggesting minimal right-leaning media interest in this business story.
- The story received minimal overall coverage with only one substantive source, indicating this remains a niche business angle rather than a major news focus across the political spectrum.
- Center and independent outlets appear absent from coverage of this consumer trend story.
Left(1)
Center(0)
Right(1)
Get this analysis in your inbox
The Daily Spectrum: one email, three perspectives on the day's biggest stories.
Free forever. Unsubscribe anytime. No spam.